High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders A Caivano, I Laurenzana, L De Luca, F La Rocca, V Simeon, S Trino, ... Tumor Biology 36, 9739-9752, 2015 | 205 | 2015 |
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer DS Matassa, MR Amoroso, H Lu, R Avolio, D Arzeni, C Procaccini, ... Cell Death & Differentiation 23 (9), 1542-1554, 2016 | 187 | 2016 |
Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-γ D De Stefano, MC Maiuri, V Simeon, G Grassia, A Soscia, MP Cinelli, ... European journal of pharmacology 566 (1-3), 192-199, 2007 | 146 | 2007 |
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and … G Viscardi, AC Tralongo, F Massari, M Lambertini, V Mollica, A Rizzo, ... European Journal of Cancer 177, 175-185, 2022 | 136 | 2022 |
Efficacy and durability of multifactorial intervention on mortality and MACEs: A randomized clinical trial in type-2 diabetic kidney disease FC Sasso, PC Pafundi, V Simeon, L De Nicola, P Chiodini, R Galiero, ... Cardiovascular Diabetology 20, 1-12, 2021 | 125 | 2021 |
MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a … L De Luca, S Trino, I Laurenzana, V Simeon, G Calice, S Raimondo, ... Oncotarget 7 (6), 6676, 2015 | 117 | 2015 |
Prevalence of malocclusion, oral parafunctions and temporomandibular disorder‐pain in Italian schoolchildren: An epidemiological study S Perrotta, R Bucci, V Simeon, S Martina, A Michelotti, R Valletta Journal of oral rehabilitation 46 (7), 611-616, 2019 | 103 | 2019 |
A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy V Conti, G Russomanno, G Corbi, G Toro, V Simeon, W Filippelli, ... International journal of molecular sciences 16 (3), 5452-5466, 2015 | 103 | 2015 |
Impact of fixed orthodontic appliance and clear aligners on the periodontal health: a prospective clinical study AC Pango Madariaga, R Bucci, R Rongo, V Simeon, V D’Antò, R Valletta Dentistry journal 8 (1), 4, 2020 | 99 | 2020 |
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial S De Placido, C Gallo, M De Laurentiis, G Bisagni, G Arpino, MG Sarobba, ... The Lancet Oncology 19 (4), 474-485, 2018 | 99 | 2018 |
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia P Musto, V Simeon, MC Martorelli, MT Petrucci, N Cascavilla, ... Leukemia 28 (1), 222-225, 2014 | 93 | 2014 |
MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies-a short report A Caivano, F La Rocca, V Simeon, M Girasole, S Dinarelli, I Laurenzana, ... Cellular Oncology 40, 97-103, 2017 | 92 | 2017 |
F‐18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B‐cell lymphoma R Gallicchio, G Mansueto, V Simeon, A Nardelli, R Guariglia, ... European journal of haematology 92 (5), 382-389, 2014 | 86 | 2014 |
Aging-related changes in oxidative stress response of human endothelial cells V Conti, G Corbi, V Simeon, G Russomanno, V Manzo, N Ferrara, ... Aging clinical and experimental research 27, 547-553, 2015 | 85 | 2015 |
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns I Cifola, M Lionetti, E Pinatel, K Todoerti, E Mangano, A Pietrelli, S Fabris, ... Oncotarget 6 (19), 17543, 2015 | 83 | 2015 |
Ceftazidime-avibactam combination therapy compared to ceftazidime-avibactam monotherapy for the treatment of severe infections due to carbapenem-resistant pathogens: a … M Fiore, A Alfieri, S Di Franco, MC Pace, V Simeon, G Ingoglia, ... Antibiotics 9 (7), 388, 2020 | 78 | 2020 |
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial F Perrone, M De Laurentiis, S De Placido, M Orditura, S Cinieri, F Riccardi, ... European Journal of Cancer 118, 178-186, 2019 | 78 | 2019 |
Oxidative stress effects on endothelial cells treated with different athletes’ sera V Conti, G Corbi, G Russomanno, V Simeon, N Ferrara, W Filippelli, ... Med Sci Sports Exerc 44 (1), 39-49, 2012 | 76 | 2012 |
Clinical radiobiology of glioblastoma multiforme P Pedicini, A Fiorentino, V Simeon, P Tini, C Chiumento, L Pirtoli Strahlenther Onkol 190 (10), 925-932, 2014 | 69 | 2014 |
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc … FC Sasso, V Simeon, R Galiero, A Caturano, L De Nicola, P Chiodini, ... Cardiovascular Diabetology 21 (1), 235, 2022 | 66 | 2022 |